Barclays’s AllianzIM U.S. Equity Buffer10 Nov ETF NVBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.93K Hold
72
– – ﹤0.01% 4930
2026
Q2
$2.85K Buy
+72
New +$2.78K ﹤0.01% 4835
2025
Q4
– Sell
-4,829
Closed -$175K – 5545
2025
Q3
$175K Sell
4,829
-686
-12% -$24.2K ﹤0.01% 4393
2025
Q2
$189K Buy
5,515
+993
+22% +$32.2K ﹤0.01% 4319
2025
Q1
$144K Buy
+4,522
New +$148K ﹤0.01% 4245

Other funds holding NVBT

Barclays's NVBT Position: Q3 2026 in Review

Barclays held its AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) position steady in Q3 2026 at 72 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #4930.

Barclays first reported a position in NVBT in Q1 2025 and has held it in 5 quarters since. The position peaked at $189K in Q2 2025. 13 funds tracked by Wall St. Rank hold NVBT as of Q3 2026.

  • Barclays held 72 shares of AllianzIM U.S. Equity Buffer10 Nov ETF worth $2.93K as of Q3 2026.
  • Barclays left its AllianzIM U.S. Equity Buffer10 Nov ETF share count unchanged in Q3 2026.
  • AllianzIM U.S. Equity Buffer10 Nov ETF made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4930 holding.
  • Barclays first reported a position in AllianzIM U.S. Equity Buffer10 Nov ETF in Q1 2025 and has held it in 5 quarters since.
  • Barclays's AllianzIM U.S. Equity Buffer10 Nov ETF position peaked at $189K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Nov ETF as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.